… Harvard Teaching Hospitals funded to develop dopamine neuron replacement treatment Parkinson’s … Markers Initiative making iPSCs available to broad research community Dopamine neurons engineered from iPSCs may hold … colleagues published the first evidence of iPSC protocols, showing the function of human midbrain dopamine neurons. Read …

… on Local Opportunities to Join the Pursuit for a Cure NEW YORK, NY - The Michael J. Fox Foundation for Parkinson's … (MJFF) will host a Clinical Trials Fair in New York City on Saturday, October 19, to raise awareness and …

… for Parkinson's Disease and Lewy Body Dementia Promising Outcomes of Original Grant: In our original study, the aim was to develop computational tools based on signal processing … in understanding the evolution of these diseases and how they affect the performance of our system, which in turn …

… Access to comprehensive research data provides unprecedented … barrier to entry in brain disease research — is becoming more feasible as multidisciplinary teams partner on … data available in BRAIN Commons is de-identified and supported by participants' informed consent. In the coming …

… available and have a better-known safety profile than a completely new drug. Certain drugs used for treating other … diseases (e.g., hypertension, diabetes) have been linked to lower risk of Parkinson’s in epidemiological studies and have been tested for ability to delay the progress of Parkinson’s …

… time the disorder is recognized and diagnosed, it is often too late to protect or reverse the damage that has … blood plasma. Study Design:  The Chronos-PD study will use complementary cutting-edge proteomics technologies to … will lead to the identification of new candidate drug targets that could modify disease trajectory. It will also lead …